Efficacy of Credelio Quattro™ (lotilaner, moxidectin, pyrantel, praziquantel) and Credelio™ (lotilaner) against longhorned tick, Haemaphysalis longicornis,-induced infestations on dogs.
Scott Wiseman, Molly D Savadelis, Riaan Maree, Mandie Momberg, Liezl Whitehead, Lisa Young
{"title":"Efficacy of Credelio Quattro<sup>™</sup> (lotilaner, moxidectin, pyrantel, praziquantel) and Credelio<sup>™</sup> (lotilaner) against longhorned tick, Haemaphysalis longicornis,-induced infestations on dogs.","authors":"Scott Wiseman, Molly D Savadelis, Riaan Maree, Mandie Momberg, Liezl Whitehead, Lisa Young","doi":"10.1186/s13071-025-06965-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Haemaphysalis longicornis, the longhorned tick, is an invasive tick species that has been identified in increasing numbers and regions across the USA. This tick species is a competent vector for various pathogens to dogs, humans, and other species, with heavy infestations documented to lead to exsanguination. Therefore, determination of ectoparasiticides providing adequate treatment and control of H. longicornis is imperative to help reduce vector-borne disease transmission and protect against infestation in dogs.</p><p><strong>Methods: </strong>Three laboratory studies were conducted to evaluate the efficacy of Credelio Quattro and Credelio for the treatment and control of H. longicornis. A total of 30 dogs per study were randomized to receive either placebo, Credelio Quattro, or Credelio on Day 0 according to a complete block design on the basis of pre-treatment live attached H. longicornis counts, infested on Day -7. To assess efficacy against preexisting infestations, enrolled dogs were infested with 50 unfed adult H. longicornis on Day -2 or -1 prior to treatment. Residual efficacy post-treatment was evaluated with subsequent infestations on Days 5, 12, 19, and 30. All ticks were collected and evaluated as live or dead and free or attached 48 h after treatment or infestation.</p><p><strong>Results: </strong>Adequacy of infestation was achieved in at least two studies for every infestation time point evaluated. Both Credelio Quattro and Credelio provided 100% efficacy against H. longicornis from Day 2 through Day 32, with no live ticks observed on any dogs. A statistically significant number of dead ticks were recovered from both treated groups as compared with control on all assessment days. Post-treatment, treatment-related diarrhea was reported in six dogs receiving Credelio Quattro and one dog receiving Credelio on Day 0, with all dogs recovering on Day 1.</p><p><strong>Conclusions: </strong>The laboratory studies described confirm the safety and effectiveness of a single dose of Credelio Quattro and Credelio, at the minimum effective dosage of 20 mg/kg lotilaner, 0.02 mg/kg moxidectin, 5 mg/kg praziquantel, 5 mg/kg pyrantel, and 20 mg/kg lotilaner, respectively, for the treatment and control of H. longicornis infestations in dogs for one month.</p>","PeriodicalId":19793,"journal":{"name":"Parasites & Vectors","volume":"18 1","pages":"344"},"PeriodicalIF":3.5000,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12351792/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Parasites & Vectors","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13071-025-06965-y","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PARASITOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Haemaphysalis longicornis, the longhorned tick, is an invasive tick species that has been identified in increasing numbers and regions across the USA. This tick species is a competent vector for various pathogens to dogs, humans, and other species, with heavy infestations documented to lead to exsanguination. Therefore, determination of ectoparasiticides providing adequate treatment and control of H. longicornis is imperative to help reduce vector-borne disease transmission and protect against infestation in dogs.
Methods: Three laboratory studies were conducted to evaluate the efficacy of Credelio Quattro and Credelio for the treatment and control of H. longicornis. A total of 30 dogs per study were randomized to receive either placebo, Credelio Quattro, or Credelio on Day 0 according to a complete block design on the basis of pre-treatment live attached H. longicornis counts, infested on Day -7. To assess efficacy against preexisting infestations, enrolled dogs were infested with 50 unfed adult H. longicornis on Day -2 or -1 prior to treatment. Residual efficacy post-treatment was evaluated with subsequent infestations on Days 5, 12, 19, and 30. All ticks were collected and evaluated as live or dead and free or attached 48 h after treatment or infestation.
Results: Adequacy of infestation was achieved in at least two studies for every infestation time point evaluated. Both Credelio Quattro and Credelio provided 100% efficacy against H. longicornis from Day 2 through Day 32, with no live ticks observed on any dogs. A statistically significant number of dead ticks were recovered from both treated groups as compared with control on all assessment days. Post-treatment, treatment-related diarrhea was reported in six dogs receiving Credelio Quattro and one dog receiving Credelio on Day 0, with all dogs recovering on Day 1.
Conclusions: The laboratory studies described confirm the safety and effectiveness of a single dose of Credelio Quattro and Credelio, at the minimum effective dosage of 20 mg/kg lotilaner, 0.02 mg/kg moxidectin, 5 mg/kg praziquantel, 5 mg/kg pyrantel, and 20 mg/kg lotilaner, respectively, for the treatment and control of H. longicornis infestations in dogs for one month.
期刊介绍:
Parasites & Vectors is an open access, peer-reviewed online journal dealing with the biology of parasites, parasitic diseases, intermediate hosts, vectors and vector-borne pathogens. Manuscripts published in this journal will be available to all worldwide, with no barriers to access, immediately following acceptance. However, authors retain the copyright of their material and may use it, or distribute it, as they wish.
Manuscripts on all aspects of the basic and applied biology of parasites, intermediate hosts, vectors and vector-borne pathogens will be considered. In addition to the traditional and well-established areas of science in these fields, we also aim to provide a vehicle for publication of the rapidly developing resources and technology in parasite, intermediate host and vector genomics and their impacts on biological research. We are able to publish large datasets and extensive results, frequently associated with genomic and post-genomic technologies, which are not readily accommodated in traditional journals. Manuscripts addressing broader issues, for example economics, social sciences and global climate change in relation to parasites, vectors and disease control, are also welcomed.